The pharmaceutical industry is staring down a major patent cliff, with key drugs from Merck (MRK), Bristol Myers Squibb (BMY), and Johnson & Johnson (JNJ) set to lose exclusivity by 2030. Yahoo ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.

Hims & Hers (HIMS) stock is nosediving after Novo Nordisk (NVO) ended its deal with the company over continued sales of ...

Brian Schottenheimer is connecting his players with the team's past legends; Ravens WR Rashod Bateman reveals how close he ...

Parkin wrapped up her stellar prep career with an all-state nod as a catcher. The slugging standout and reigning 1A Evergreen ...

See how Ina Garten’s style, charm, and career have evolved in stunning throwback photos; From her wedding day to becoming the ...

This article was featured in One Great Story, New York’s reading recommendation newsletter. Sign up here to get it nightly.

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.

The Supreme Court has come to a highly anticipated decision in the case related to birthright citizenship. The issue before the court was how lower courts should handle President Trump's executive ...